Tiotropium Handihaler vs. Tiotropium Respimat in COPD
Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if tiotropium Respimat will result in better
ventilation distribution of the lung in COPD participants quantified by hyperpolarized XeMRI.
This study is designed to simulate the real-life clinical setting where patients receive
one-time instruction on the inhaler use.